GSK has expanded its ongoing share buyback program, repurchasing 467,000 ordinary shares on February 20, 2026, and holding them in treasury. This latest buyback brings GSK’s total treasury holdings to 241,658,094 shares, representing 5.93% of the company’s voting rights. This information is crucial for investors tracking FCA disclosure thresholds.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
GSK Expands Share Buyback, Lifts Treasury Holdings to 5.93% of Voting Rights
GSK has expanded its ongoing share buyback program, repurchasing 467,000 ordinary shares on February 20, 2026, and holding them in treasury. This latest buyback brings GSK’s total treasury holdings to 241,658,094 shares, representing 5.93% of the company’s voting rights. This information is crucial for investors tracking FCA disclosure thresholds.